European committee takes a second look at Alzheimer's drug and now says it should be approved
A European regulatory committee now recommends approval of the Alzheimer’s treatment lecanemab a few months after rejecting ...
STAT2h
Changing course, European regulators now say Alzheimer’s treatment Leqembi should be approved
Reversing an earlier decision, European regulators recommended that an Alzheimer’s therapy from Eisai and Biogen should be ...
Yahoo1h
European watchdog partially approves new Alzheimer's drug
has recommended granting marketing authorisation to Leqembi (lecanemab) for treating mild cognitive impairment or mild ...